Milestone
3.1.b
Funding for egg-independent methods
In progress
Provide funding (such as through private-public partnerships) to further develop the most promising egg-independent vaccine production methods.
Progress Highlights
BARDA Strategic Plan 2022-2026 outlined a plan to improve the manufacturing and fill-finish capacity for seasonal influenza vaccines and to advance the development of vaccines against pandemic influenza through public-private partnerships, as part of BARDA’s role in the National Influenza Vaccine Modernization Strategy (NIVMS), 2020-2030.